Barings’s PharMerica Corporation PMC Stock Holding History

Barings’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-7,900	Closed	-$226K	–	1005
2014 Q2	$226K	Sell	7,900 -1,100	-12%	-$30.6K	0.01%	903
2014 Q1	$252K	Buy	+9,000	New	+$221K	0.01%	836
2013 Q4	–	Sell	-10,500	Closed	-$139K	–	1002
2013 Q3	$139K	Buy	+10,500	New	+$141K	0.01%	904

Other funds holding PMC

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MCM

Munder Capital Management Birmingham, Michigan $13.4B AUM 18.35% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Barings's PMC Position: Q3 2014 in Review

Barings sold out of PharMerica Corporation (PMC) in Q3 2014, closing a stake of 7,900 shares — an estimated $226K sold.

Barings first reported a position in PMC in Q3 2013 and held it in 3 quarters. The position peaked at $252K in Q1 2014. 161 funds tracked by Wall St. Rank hold PMC as of Q3 2014.

Barings reported no remaining PharMerica Corporation position as of Q3 2014 after selling out during the quarter.
Barings sold 7,900 PharMerica Corporation shares in Q3 2014, an estimated $226K.
Barings first reported a position in PharMerica Corporation in Q3 2013 and held it in 3 quarters.
Barings's PharMerica Corporation position peaked at $252K in Q1 2014.
161 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2014.

Based on Barings's 13F filing for Q3 2014, filed 14 Nov 2014.